Related references
Note: Only part of the references are listed.Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
Andrea Chiricozzi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22
Gregory F. Sonnenberg et al.
NATURE IMMUNOLOGY (2011)
Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1α, and TNF-α Recapitulates Some Features of Psoriasis
Karline Guilloteau et al.
JOURNAL OF IMMUNOLOGY (2010)
Skin-Resident T Cells: The Ups and Downs of On Site Immunity
Rachael A. Clark
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
Pieter C. M. Res et al.
PLOS ONE (2010)
IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression
Mikiko Tohyama et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
Lisa C. Zaba et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Cytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin Diseases
Leanne M. Johnson-Huang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
IL-23 Drives Pathogenic IL-17-Producing CD8(+) T Cells
Bogoljub Ciric et al.
JOURNAL OF IMMUNOLOGY (2009)
Resident and Inflammatory'' Dendritic Cells in Human Skin
Lisa C. Zaba et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
Erin G. Harper et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Matrix-Degrading Metalloproteinases in Photoaging
Taihao Quan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2009)
IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not
Kerstin Wolk et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Thomas Duhen et al.
NATURE IMMUNOLOGY (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Insights into gene modulation by therapeutic TNF and IFN gamma antibodies: TNF regulates IFN gamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome
Asifa S. Haider et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes
Kerstin Wolk et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
Lisa C. Zaba et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis
Angela Moore et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Pathogenesis and therapy of psoriasis
Michelle A. Lowes et al.
NATURE (2007)
The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis
Susan M. Sa et al.
JOURNAL OF IMMUNOLOGY (2007)
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng et al.
NATURE (2007)
Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs
Stefanie Kunz et al.
EXPERIMENTAL DERMATOLOGY (2006)
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Spencer C. Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis:: Gene regulation and cellular effects
Frank Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis
K Otkjaer et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-κB and activator protein-1 in inflammatory acne lesions in vivo
S Kang et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Amphiregulin and epidermal hyperplasia - Amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice
N Bhagavathula et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes
K Boniface et al.
JOURNAL OF IMMUNOLOGY (2005)
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris
E Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment
RG Langley et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization
ML Nagalakshmi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes
M Piepkorn et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2003)
Epidermal overexpression of interleukin-19 and-20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine A or calcipotriol
J Romer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Interleukins 19, 20, and 24 signal through two distinct receptor complexes - Differences in receptor-ligand interactions mediate unique biological functions
JP Novak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cutting edge: Immune cells as sources and targets of the IL-10 family members?
K Wolk et al.
JOURNAL OF IMMUNOLOGY (2002)
The immunologic basis for the treatment of psoriasis with new biologic agents
JG Krueger
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types
L Dumoutier et al.
JOURNAL OF IMMUNOLOGY (2001)
Interleukin 20: Discovery, receptor identification, and role in epidermal function
H Blumberg et al.
CELL (2001)